Immunocore Holdings (IMCR) Free Cash Flow (2023 - 2025)
Historic Free Cash Flow for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to -$5.2 million.
- Immunocore Holdings' Free Cash Flow fell 12563.67% to -$5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 8516.58%. This contributed to the annual value of $20.9 million for FY2024, which is 94056.34% up from last year.
- According to the latest figures from Q3 2025, Immunocore Holdings' Free Cash Flow is -$5.2 million, which was down 12563.67% from $25.5 million recorded in Q2 2025.
- Immunocore Holdings' Free Cash Flow's 5-year high stood at $25.5 million during Q2 2025, with a 5-year trough of -$35.8 million in Q1 2021.
- In the last 5 years, Immunocore Holdings' Free Cash Flow had a median value of -$3.2 million in 2023 and averaged -$3.6 million.
- Over the last 5 years, Immunocore Holdings' Free Cash Flow had its largest YoY gain of 181414.81% in 2024, and its largest YoY loss of 16655.61% in 2024.
- Quarter analysis of 5 years shows Immunocore Holdings' Free Cash Flow stood at -$35.6 million in 2021, then soared by 51.51% to -$17.3 million in 2022, then decreased by 7.31% to -$18.6 million in 2023, then grew by 5.47% to -$17.5 million in 2024, then soared by 70.32% to -$5.2 million in 2025.
- Its Free Cash Flow was -$5.2 million in Q3 2025, compared to $25.5 million in Q2 2025 and $137000.0 in Q1 2025.